Amalgamated Bank’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,783
| Closed | -$16K | – | 3028 |
|
|
2025
Q2 | $16K | Hold |
1,783
| – | – | ﹤0.01% | 2214 |
|
|
2025
Q1 | $14K | Hold |
1,783
| – | – | ﹤0.01% | 2230 |
|
|
2024
Q4 | $10K | Hold |
1,783
| – | – | ﹤0.01% | 2444 |
|
|
2024
Q3 | $13K | Hold |
1,783
| – | – | ﹤0.01% | 2335 |
|
|
2024
Q2 | $19K | Hold |
1,783
| – | – | ﹤0.01% | 2145 |
|
|
2024
Q1 | $33K | Sell |
1,783
-5,521
| -76% | -$127K | ﹤0.01% | 1979 |
|
|
2023
Q4 | $158K | Sell |
7,304
-530
| -7% | -$10.5K | ﹤0.01% | 1866 |
|
|
2023
Q3 | $161K | Hold |
7,834
| – | – | ﹤0.01% | 1851 |
|
|
2023
Q2 | $368K | Buy |
7,834
+2,377
| +44% | +$118K | ﹤0.01% | 1578 |
|
|
2023
Q1 | $229K | Sell |
5,457
-1,507
| -22% | -$64.8K | ﹤0.01% | 1746 |
|
|
2022
Q4 | $266K | Buy |
6,964
+235
| +3% | +$8.97K | ﹤0.01% | 1746 |
|
|
2022
Q3 | $264K | Buy |
6,729
+155
| +2% | +$5.99K | ﹤0.01% | 1739 |
|
|
2022
Q2 | $212K | Sell |
6,574
-2,404
| -27% | -$80.6K | ﹤0.01% | 1855 |
|
|
2022
Q1 | $297K | Sell |
8,978
-311
| -3% | -$11.7K | ﹤0.01% | 1776 |
|
|
2021
Q4 | $395K | Sell |
9,289
-7,765
| -46% | -$325K | ﹤0.01% | 1691 |
|
|
2021
Q3 | $756K | Sell |
17,054
-489
| -3% | -$22.4K | 0.01% | 1388 |
|
|
2021
Q2 | $997K | Buy |
17,543
+11,323
| +182% | +$800K | 0.01% | 1291 |
|
|
2021
Q1 | $466K | Sell |
6,220
-439
| -7% | -$36K | 0.02% | 1025 |
|
|
2020
Q4 | $576K | Sell |
6,659
-17
| -0.3% | -$1.25K | 0.02% | 891 |
|
|
2020
Q3 | $408K | Sell |
6,676
-2
| -0% | -$101 | 0.02% | 954 |
|
|
2020
Q2 | $278K | Sell |
6,678
-6,645
| -50% | -$241K | 0.01% | 1154 |
|
|
2020
Q1 | $383K | Sell |
13,323
-228
| -2% | -$13.2K | 0.01% | 1029 |
|
|
2019
Q4 | $978K | Buy |
13,551
+921
| +7% | +$113K | 0.02% | 811 |
|
|
2019
Q3 | $1.77M | Buy |
12,630
+1,487
| +13% | +$249K | 0.04% | 499 |
|
|
2019
Q2 | $2.04M | Buy |
11,143
+99
| +0.9% | +$16.9K | 0.05% | 383 |
|
|
2019
Q1 | $1.76M | Buy |
11,044
+876
| +9% | +$127K | 0.04% | 457 |
|
|
2018
Q4 | $974K | Buy |
10,168
+3,930
| +63% | +$450K | 0.03% | 656 |
|
|
2018
Q3 | $881K | Sell |
6,238
-4,383
| -41% | -$677K | 0.02% | 740 |
|
|
2018
Q2 | $1.66M | Buy |
10,621
+4,998
| +89% | +$785K | 0.04% | 480 |
|
|
2018
Q1 | $906K | Buy |
5,623
+476
| +9% | +$80.8K | 0.02% | 738 |
|
|
2017
Q4 | $848K | Buy |
5,147
+744
| +17% | +$72.1K | 0.02% | 775 |
|
|
2017
Q3 | $274K | Buy |
4,403
+25
| +0.6% | +$1.96K | 0.01% | 1262 |
|
|
2017
Q2 | $349K | Buy |
4,378
+686
| +19% | +$49.6K | 0.01% | 1111 |
|
|
2017
Q1 | $262K | Buy |
+3,692
| New | +$216K | 0.01% | 1224 |
|
Other funds holding SAGE
IA
HNB